3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Opiant Pharmaceuticals Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens Nalmefene Hydrochloride - Opioid Overdose | Phase 1 | Completed | Opiant Pharmaceuticals Inc | 24 | 2021-09-01 | 2024-08-05 |
| Pharmacodynamic Evaluation of Intranasal Nalmefene Nalmefene hydrochloride, Naloxone hydrochloride - Pharmacodynamic | Phase 1 | Completed | Opiant Pharmaceuticals Inc | 84 | 2021-03-30 | 2025-07-14 |
| Pharmacokinetic Evaluation of Intranasal Nalmefene Nalmefene Hydrochloride, Nalmefene - Pharmacokinetics | Phase 1 | Completed | Opiant Pharmaceuticals Inc | 68 | 2021-02-08 | 2024-08-13 |
Opiate Overdose (1)
United States (3)
Ingela Danielsson, MD (1) · Robert Bass, MD (1) · Shawn Searle, MD (1)